Advertisement
Advertisement
Business of climate change
Get more with myNEWS
A personalised news feed of stories that matter to you
Learn more
CellX co-founder and CEO Ziliang Yang speaks at the launch of the start-up’s cultivated meat pilot factory in Shanghai on Wednesday. Photo: Handout

Shanghai-based CellX a step closer to bringing cultivated meat to market with launch of China’s first pilot plant

  • The CellX plant in Shanghai has a 2,000 litre bioreactor with a capacity to produce ‘single-digit tonnes’ of cultivated meat per year, CEO Ziliang Yang says
  • The start-up plans to approach food regulators in the US and Singapore to approve their for products sale later this year

Shanghai-based cell-grown meat start-up CellX launched China’s first cultivated meat pilot factory on Wednesday, a significant breakthrough in the nation’s quest for a sustainable source of animal protein to feed its population.

The pilot plant represents a step closer to bringing cultivated meat to dining tables before large-scale production, co-founder and CEO Ziliang Yang said in an interview.

The plant in Shanghai has a 2,000 litre bioreactor with a capacity to produce “single-digit tonnes” of cultivated meat per year, Yang said, with more bioreactors to be added soon.

“The insights from this pilot facility will be used for our commercial production facility that we’re planning to complete by 2025 [which] will be able to produce hundreds of tonnes of products per year,” said Yang.

Dishes made from CellX’s cultivated meat products. Photo: Handout

Ensuring food security for its 1.4 billion people, around a fifth of the world’s population, has become one of China’s top priorities as part of its strategy to cut reliance on imports.

In May 2022, Beijing expressed its support for the development of synthetic protein as a food source to reduce the pressures on environmental resources brought on by traditional livestock breeding, as part of its 14th five-year development plan for the bio-economy. This was preceded by the inclusion of lab-grown meat and other alternative proteins in January to ensure a sustainable food supply.

01:44

Would you eat this 3D printed plant-based steak?

Would you eat this 3D printed plant-based steak?

Yang said the pilot facility will help to reduce CellX’s production cost to below US$100 per pound, making it competitive against premium meats, he said, adding that the launch of CellX’s commercial production facility in 2025 will further reduce costs.

In comparison, one pound of A5 grade Japanese Wagyu Kobe beef sells for around US$189 on Amazon.

“The fact that we’re able to do pilots and reduce costs below US$100 per pound is really a major milestone that signifies the transition from R&D to production,” said Yang. “Industrialisation and commercialisation is something that we will focus on next.”

Later this year, CellX plans to approach food regulators in the US and Singapore to approve its products for sale followed by other international markets in 2025.

02:25

Scientists in Japan create 3D-printed Wagyu beef

Scientists in Japan create 3D-printed Wagyu beef
In June, the US became the second country after Singapore to allow the sale of cultivated meat after Upside Foods and Good Meat received the go-ahead from the US Department of Agriculture to sell lab-grown meat.

Cultivated meat is produced by cultivating animal cells directly, eliminating the need to raise animals for food.

Singapore allowed the sale of cultured meat in December 2020, when start-up Eat Just received approval to sell its laboratory-created chicken in the city state.

CellX, which debuted samples of its cell-based pork products in September 2021, adopts a multi-species approach for its cultivated meat products.

Founded in 2020, CellX has raised around US$20 million from four rounds of investment from strategic investors such as Joyvio Capital, which is backed by China’s Legend Holdings, and South Korean conglomerate SK Group.
CellX signed a strategic partnership with Berlin-based Bluu Seafood in April 2022 to help both companies drive regulatory compliance and expand consumer acceptance of lab-grown protein products in the Chinese and European markets.
1